Dunn v. Sanofi-Aventis U.S. LLC

CourtDistrict Court, M.D. Alabama
DecidedJanuary 26, 2024
Docket3:23-cv-00649
StatusUnknown

This text of Dunn v. Sanofi-Aventis U.S. LLC (Dunn v. Sanofi-Aventis U.S. LLC) is published on Counsel Stack Legal Research, covering District Court, M.D. Alabama primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Dunn v. Sanofi-Aventis U.S. LLC, (M.D. Ala. 2024).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE MIDDLE DISTRICT OF ALABAMA EASTERN DIVISION

MAGGIE DUNN, ) ) Plaintiff, ) ) v. ) CIVIL CASE NO. 3:23-cv-649-ECM ) [WO] SANOFI-AVENTIS U.S. LLC, et al., ) ) Defendants. )

O R D E R Now pending before the Court is Plaintiff Maggie Dunn’s motion for leave to amend her complaint. (Doc. 32). Defendants Sanofi-Aventis U.S. LLC and Sanofi US Services Inc. filed a response in opposition to the motion. (Doc. 34). Having reviewed the parties’ submissions, the Court concludes that Dunn’s motion is due to be DENIED. I. LEGAL STANDARD “A party may amend its pleading once as a matter of course no later than . . . 21 days after serving it.” FED. R. CIV. PRO. 15(a)(1). “In all other cases a party may amend its pleading only with the opposing party’s written consent or the court’s leave.” FED. R. CIV. PRO. 15(a)(2). “[L]eave to amend shall be freely given when justice so requires,” Maynard v. Bd. of Regents of Div. of Universities of Fla. Dep’t of Educ. ex rel. Univ. of S. Fla., 342 F.3d 1281, 1287 (11th Cir. 2003) (citation omitted), but “it is ‘not an automatic right.’” Reese v. Herbert, 527 F.3d 1253, 1263 (11th Cir. 2008) (citation omitted). The Court may deny leave “where there is substantial ground for doing so, such as ‘undue delay, bad faith or dilatory motive on the part of the movant, repeated failure to cure deficiencies by amendments previously allowed, undue prejudice to the opposing party by virtue of allowance of the amendment, [and] futility of amendment.’” Reese v. Herbert, 527 F.3d

1253, 1263 (11th Cir. 2008) (alteration in original) (citing Burger King Corp. v. Weaver, 169 F.3d 1310, 1319 (11th Cir. 1999)). II. DISCUSSION The case before the Court was remanded from the multidistrict litigation In re: Taxotre (Docetaxel) Products Liability Litigation, No. 2:16-md-2740 (J.P.M.L.) (“the MDL Court”). The Plaintiff filed the instant case on November 25, 2017, and it was

remanded to this Court from the MDL Court on November 3, 2023. The operative pleadings consist of the Second Amended Master Complaint (doc. 9-4 at 342) and the Plaintiff’s Short Form Complaint (doc. 1), which contains her individual allegations. The Plaintiff seeks to file an amended long-form complaint. The MDL Court stated upon remand to this Court that “[a]ll deadlines for Plaintiffs to amend their individual complaints

without leave of court have passed.” (Doc. 10 at 76).1 The Defendants also oppose the motion. (Doc. 34). Dunn seeks to amend her complaint “to provide case-specific details, including allegations and details related to, among other things, her specific injury and timing, Defendants’ fraudulent concealment of facts . . . , and punitive damages.” (Doc. 32 at 1).

The Plaintiff represents in her motion that “there were no amendments allowed [in the

1 This Court has not entered a scheduling order in this case. Neither party has argued that the MDL Court’s scheduling order should be modified pursuant to Rule 16(b). Thus, the Court only considers the amendment pursuant to Rule 15(a). MDL] beyond amending the short form complaint which contained text boxes and checkboxes for minimal/form case-specific allegations.” (Doc. 32 at 1). Further, the

Plaintiff contends that the Short Form Complaint “did not provide Plaintiff with a text box inviting allegations of any case-specific facts regarding her knowledge of a link between Taxotere and the [sic.] Ms. Dunn’s permanent hair loss injury.” (Doc. 32 at 3). Therefore, she was “unable to allege case specific facts beyond those set forth in the master and short form complaint.” (Doc. 32 at 1). The Defendants take issue with the Plaintiff’s amendment for three reasons. First,

they contend that the Plaintiff is seeking to redefine her injury with an amendment identical to one already rejected by the MDL Court, and this Court should uphold the MDL Court’s orders under the law of the case doctrine. Second, the Defendants argue that the Plaintiff had opportunities to amend her Short Form Complaint in the MDL proceedings to add allegations regarding her fraud claims and the statute of limitations, but she failed to do so.

Finally, they contend that it would be futile to permit the amendment, as the Plaintiff’s claims would still be barred by the statute of limitations and fail Rule 9(b)’s heightened pleading standard. A. The MDL Proceedings After the Defendants in the previous MDL proceedings moved to dismiss the fraud

claims in the Master Complaint for failure to plead with particularity, the MDL Court acknowledged in an August 30, 2017 hearing before Judge Engelhardt that “a master complaint could not possibly be expected to include every case-specific detail such as a particular misleading statement made by a particular sales representative to the physician of an individual plaintiff.” Hearing Transcript, Doc. 823, at 22, In re: Taxotre, 2:16-md- 02740. Thus, the Court considers both the Master Complaint and the Plaintiff’s Short Form

Complaint in deciding the sufficiency of the pleadings. (Id.). The MDL Court then ruled that “specific allegations, particularly with respect to fraud, should be perfected within the short form complaints filed in the individual member cases.” (Id. at 23).2 The Plaintiff alleges that despite this ruling, she was unable to perfect her fraud claims in her Short Form Complaint. On December 11, 2019, the MDL Court denied the Plaintiffs’ Steering Committee’s

motion for leave to file a Third Amended Master Complaint, where the plaintiffs sought to “no longer define their injury as manifesting six months after chemotherapy” and to “describe in greater detail ‘the actions and inactions of Defendants that [are] alleged to have caused harm to the plaintiffs in this litigation in regard to the allegations of fraudulent concealment, including but not limited to Sanofi’s marketing efforts.” (Doc. 9-4 at 1425–

26). After oral arguments and considering Rule 15(a)(2), the MDL Court found that the amendment “would negate a significant amount of work that has been done in this MDL,” additional discovery would be needed, and the amendment would moot earlier rulings by the MDL Court. (Doc. 9-4 at 1428). Consequently, the MDL Court denied the motion because the Defendants would suffer undue prejudice if the amendment were allowed.

(Doc. 9-4 at 1428). The Court also denied amendments to certain short-form complaints

2 In Case Management Order No. 39, which summarized the MDL proceedings for this Court, the MDL Court confirmed that “[the MDL Court] has ruled that any fraud-based claims must be perfected within the short form complaints filed in the individual member cases.” (Doc. 10 at 75). which sought to “buttress their claims against statute-of-limitations defenses,” because the “amendments would prompt Defendants to conduct additional discovery and prepare a

different statute-of-limitations defense.” (Doc. 9-4 at 1434). The Plaintiffs do not reference these orders in their motion, but the Defendants argue that the Plaintiff’s proposed amendments are the same as those denied by the MDL Court in these orders. On May 11, 2020, the MDL Court gave instructions for plaintiffs wishing to amend their short form complaints to address the statute of limitations, in light of an influx of motions to amend short form complaints after the Court denied the Third Amended Master

Complaint. (Doc. 9-2 at 167 (hereinafter “PTO (Pretrial Order) 105”)).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

In Re Ford Motor Co.
591 F.3d 406 (Fifth Circuit, 2009)
Burger King Corp. v. Weaver
169 F.3d 1310 (Eleventh Circuit, 1999)
Reese v. Herbert
527 F.3d 1253 (Eleventh Circuit, 2008)
United States v. Cullen Horace Williams
728 F.2d 1402 (Eleventh Circuit, 1984)
Benjamin R. Singleton v. Department of Corrections
323 F. App'x 783 (Eleventh Circuit, 2009)
Hill v. Ford Motor Co.
975 F. Supp. 2d 1351 (N.D. Georgia, 2013)

Cite This Page — Counsel Stack

Bluebook (online)
Dunn v. Sanofi-Aventis U.S. LLC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/dunn-v-sanofi-aventis-us-llc-almd-2024.